The polycystic ovary syndrome: a position statement from the Polish Society of Endocrinology, the Polish Society of Gynaecologists and Obstetricians, and the Polish Society of Gynaecological Endocrinology

Endokrynol Pol. 2018;69(4). doi: 10.5603/EP.2018.0046.

Abstract

Polycystic ovary syndrome (PCOS) diagnosis and therapy still arouse a lot of controversy. Each year brings new information, so, having collected the experience of three scientific societies, we present contemporary recommendations concerning PCOS diagnostics and treat-ment. In adult female diagnosis, we still use the Rotterdam criteria, which is two out of three of the follwing characteristics: a) ovulation abnormality, b) clinical or biochemical hyperandrogenism, and c) polycystic ovaries. In the case of teenagers, diagnostic criteria are as follows: menstruation disturbances two years after menarche and clinical or biochemical hyperandrogenism. The presence of polycysti-cally abnormal ovaries is not necessary. The consensus paper presents the threats resulting from imperfect diagnostic methods applied in PCOS (hyperandrogenism diagnostics, ultrasound examination of ovaries). Suggested therapy includes personalised schemes according to the dominant PCOS phenotype, i.e. metabolic, hyperandrogenic, or reproductive ones.

Keywords: PCOS phenotypes; diagnosis of PCOS; personalised therapy; polycystic ovary syndrome.

Publication types

  • Practice Guideline

MeSH terms

  • Adolescent
  • Adult
  • Endocrinology
  • Female
  • Gynecology
  • Humans
  • Poland
  • Polycystic Ovary Syndrome / diagnosis*
  • Polycystic Ovary Syndrome / therapy*
  • Societies, Medical*
  • Young Adult